Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/archotol.1954.00720010203010 | DOI Listing |
J Clin Exp Neuropsychol
October 2024
Department of Psychiatry, University of Illinois College of Medicine, Chicago, IL, USA.
Appl Neuropsychol Adult
September 2024
Cognitive Psychology and Neuropsychology Department, University of Mons, Mons, Belgium.
Cogn Behav Neurol
September 2022
Center for Translational Cognitive Neuroscience, Veterans Affairs Boston Healthcare System, Boston, Massachusetts.
Background: Individuals with probable Alzheimer disease (AD) may perform below cutoffs on traditional, memory-based performance validity tests. Previous studies have found success using event-related potentials (ERPs) to detect feigned neurocognitive impairment in younger populations.
Objective: To evaluate the utility of an auditory oddball task in conjunction with the P3b peak amplitude to distinguish probable AD from simulated dementia.
PLoS One
January 2022
School of Integrated Technology, College of Engineering, Yonsei University, Seoul, South Korea.
Diagnostic tests for hearing impairment not only determines the presence (or absence) of hearing loss, but also evaluates its degree and type, and provides physicians with essential data for future treatment and rehabilitation. Therefore, accurately measuring hearing loss conditions is very important for proper patient understanding and treatment. In current-day practice, to quantify the level of hearing loss, physicians exploit specialized test scores such as the pure-tone audiometry (PTA) thresholds and speech discrimination scores (SDS) as quantitative metrics in examining a patient's auditory function.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!